TABLE 2.
Univariate analysis | ||
---|---|---|
HR (95% CI) | p-Value | |
Age, years | 0.99 (0.98–1.01) | 0.35 |
Male sex | 0.82 (0.56–1.19) | 0.29 |
Primary tumor | ||
Rectum | – | – |
Left colon | 1.02 (0.63–1.70) | 0.93 |
Right colon | 1.50 (0.88–2.59) | 0.14 |
Primary tumor T stage | ||
T1–T2 | – | – |
T3–T4 | 1.91 (1.12–3.41) | 0.023 |
Primary tumor N stage | ||
N0 | – | – |
N? | 2.29 (1.54–3.44) | < 0.001 |
Disease-free interval, months | 0.98 (0.97–0.99) | < 0.001 |
Number of metastases | 1.17 (1.07–1.28) | < 0.001 |
Metastases size, cm | 1.08 (1.02–1.14 | 0.007 |
Preoperative CEA, ng/mL | ||
≤200 | – | – |
>200 | 1.43 (0.70–2.80) | 0.31 |
Statistically significant values given in bold
CEA carcinoembryonic antigen, HR hazard ratio, CI confidence interval